FASN and neoplasm: In GC, upregulation of enzymes such as fatty acid synthase (FASN) and transcription factors like SREBP1 has been reported, and both are emerging as tissue-based biomarkers associated with tumor progression and poor prognosis (Fernandez et al., 2020).